Cromos Pharma, where the patients are

Archives

Choose a date range

From To

Choose one or more categories

Categories:



 


Study: Merit increase budgets rising in global CRO industry

Friday, April 11, 2014 12:04 PM

A recent survey conducted by HR+Survey Solutions, a compensation consulting and research firm, found merit increase budgets are on the rise in the global CRO industry. The 2013-2014 CRO Industry Global Salary Planning Survey found while the highest reported salary increase budget across the globe for 2013 was 21%, that figure rose to 25% for 2014. The country with the highest average budgeted increase is Argentina, with an average increase of 16.1% for 2014. The country with the lowest average budget increase is Portugal, with an average increase budget of only 1.8%. This compares to the overall global average budgeted increase for 2014 of 4.1%.

More... »

CRF Health eCOA webinar series

Report: Growing divide between drug development, healthcare system in U.K.

Friday, April 11, 2014 12:02 PM

The Association of the British Pharmaceutical Industry (ABPI) has issued a report that findsover half of the active products in the global industry research pipeline are personalized medicines, and the U.K. healthcare system is at risk of failing to adapt to this new challenge. The report highlights the emergence of specialized medicines as a key challenge for the U.K. pharmaceutical industry and says for the commercial environment in the U.K. to respond to this challenge, a fundamental shift in the Health Technology Assessment (HTA) approaches is needed.

More... »


Report: clinical trial management system market to reach $1.85B in 2019

Friday, April 11, 2014 12:00 PM

According to a new report from Transparency Market Research, a global market intelligence company, the global clinical trial management system market was valued at $844 million in 2013 and is expected to grow at a CAGR of 14% from 2014 to 2019, to reach an estimated value of $1.85 million in 2019.

More... »

TrialNetworks wins Disruptive Technology and Innovator of the Year Award

Friday, April 11, 2014 11:37 AM

TrialNetworks and its Clinical Trial Optimization System won the Disruptive Innovator and Technology of the Year award from Partnerships in Clinical Trials 2014. The award honors an individual or a company with a new disruptive technology platform that has increased the efficiency and quality of clinical trials. TrialNetworks technology is used by companies including Merck, Biogen Idec, Ariad Pharmaceuticals and Infinity Pharmaceuticals to optimize clinical operations from startup through closeout.

More... »

Tetra Discovery, Broad Institute to collaborate on psychiatric research

Thursday, April 10, 2014 02:02 PM

Tetra Discovery Partners, a drug discovery company developing a portfolio of innovative drugs for neurological and inflammatory diseases, has entered into a drug development collaboration with the Broad Institute's Stanley Center for Psychiatric Research in Cambridge, Mass. The focus of the collaboration will be to test the potential of Tetra's drug candidates for improving cognition in the Stanley Center's proprietary genetic models relating to schizophrenia.

More... »

Arxspan launches Safe-Biopharma signature web service

Thursday, April 10, 2014 02:01 PM

Arxspan, which develops applications for the life sciences, has created a web service that facilitates integration of SAFE-BioPharma digital signatures directly into numerous software applications.

More... »

MD Anderson, GSK form immunotherapy collaboration

Thursday, April 10, 2014 02:00 PM

The University of TexasMD Anderson Cancer Center has formed a research alliance with global pharmaceutical developer GlaxoSmithKline (GSK) to strengthen its efforts in advancing therapies that train the body's immune system to combat cancer.

More... »

Eli Lilly, T1D Exchange collaborate on new initiatives to advance diabetes care

Thursday, April 10, 2014 01:56 PM

T1D Exchange, the first program of Unitio, a nonprofit organization that helps build patient community and research platforms dedicated to eradicating chronic diseases such as type 1 diabetes, and Eli Lilly have entered into a research collaboration that will enable both organizations to gain deeper, real-world insight about the experience of people with type 1 diabetes, to identify new ways to improve care and advance outcomes.

More... »

PHARMAC promotes competition to improving patient access to high-cost medicines

Thursday, April 10, 2014 01:55 PM

PHARMAC has announced its intention to test out a contestable fund for high-cost medicines for rare disorders, which could be seeking proposals from pharmaceutical companies by the end of 2014. Promoting competition among suppliers could be the key to improving patients’ access to high-cost medicines for rare disorders, said chief executive Steffan Crausaz. The fund is a response to concerns about access to these medicines that PHARMAC has been hearing from patients through forums and consultations in recent months.

More... »

Karyopharm Therapeutics enters agreement with Clinipace Worldwide

Thursday, April 10, 2014 01:49 PM

Clinipace Worldwide, a global digital CRO (dCRO), has announced that Karyopharm Therapeutics, a clinical-stage pharmaceutical company focused on the discovery and development of novel first-in-class drugs directed against nuclear transport targets for the treatment of cancer and other major diseases, has entered into a preferred provider agreement with Clinipace to manage several clinical programs, including oncology and wound healing.

More... »

CenterWatch Drugs in Clinical Trials
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

April 14

Proposal calls for back-to-back trials to measure efficacy and effectiveness prior to FDA approval

Study: Minority populations under-represented in cancer trials, but have higher rates of incidence

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

April

Make way for mobile health in clinical trials
Despite patient retention, data quality benefits, regulatory hurdles persist

Global clinical trial laboratories decentralize
Regional labs reducing complexity, delivering cost and time savings

Already a subscriber?
Log in to your digital subscription.

Purchase the April issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

March

Strategic alliances hit bumps in the road
Mixed relationship performance driving new approaches

Tapping community hospitals for clinical trial volunteers
New study finds high potential but infrastructure, resources are lacking

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs